MoneyWorks4Me

Ajanta Pharma - Quaterly Results

06 May 2026 Evaluate
The Revenue for the quarter ended  March 2026 of Rs. 12105.30 millions grew by 19.39 % from Rs. 10139.40 millions.Net profit showed a marginal rise at Rs. 1972.80 millions for the quarter ended March 2026, as compared to corresponding quarter of last year.Operating profit surged to 3010.30 millions from the corresponding previous quarter of 2675.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 12105.30 10139.40 19.39 48459.20 43220.40 12.12 48459.20 43220.40 12.12
Other Income 629.80 179.30 251.25 2044.00 1198.70 70.52 2044.00 1198.70 70.52
PBIDT 3010.30 2675.80 12.50 14023.90 13245.90 5.87 14023.90 13245.90 5.87
Interest -7.40 6.70 -210.45 25.90 46.00 -43.70 25.90 46.00 -43.70
PBDT 3017.70 2669.10 13.06 13998.00 13199.90 6.05 13998.00 13199.90 6.05
Depreciation 441.60 387.60 13.93 1687.70 1399.30 20.61 1687.70 1399.30 20.61
PBT 2576.10 2281.50 12.91 12310.30 11800.60 4.32 12310.30 11800.60 4.32
TAX 603.30 347.20 73.76 2842.10 2631.70 7.99 2842.10 2631.70 7.99
Deferred Tax -70.00 -43.80 59.82 76.00 51.40 47.86 76.00 51.40 47.86
PAT 1972.80 1934.30 1.99 9468.20 9168.90 3.26 9468.20 9168.90 3.26
Equity 250.70 250.70 0.00 250.70 250.70 0.00 250.70 250.70 0.00
PBIDTM(%) 24.87 26.39 -5.77 28.94 30.65 -5.57 28.94 30.65 -5.57
Peers
Company Name CMP
Sun Pharma. Inds. 1860.25
Dr. Reddys Labs. 1172.35
Cipla 1380.20
Lupin 2079.95
Zydus Lifesciences 1138.45
View more..